Residual paralysis following a single dose of atracurium: results from a quality assurance trial.
Schreiber
Jan-Uwe
JU
Mucha
Eva
E
Fuchs-Buder
Thomas
T
D000328:Adult; D001279:Atracurium / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009213:Myography / Q000379:methods; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D010243:Paralysis / Q000139:chemically induced* / Q000453:epidemiology; D011183:Postoperative Complications / Q000139:chemically induced / Q000453:epidemiology; D012107:Research Design; D013997:Time Factors
D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium